Back to search

Article

Comparative <i>in vitro</i> transcriptomic analyses of COVID-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of SARS-CoV-2 host response genes

2020-04-14

Abstract excerpt

<h4>ABSTRACT</h4> Hydroxychloroquine (HCQ) has emerged as a potential and controversial antiviral candidate therapy for COVID-19. While many clinical trials are underway to test the efficacy of HCQ as a treatment for COVID-19, underlying mechanisms of HCQ in the setting of COVID-19 remain unclear. Hence, we examined differential gene expression signatures of HCQ exposure, in vitro SARS-CoV-2 infection, and host...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fc2fe73f-844f-5e12-a348-9d72bbe403ff
DOI
10.1101/2020.04.13.039263
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparative <i>in vitro</i> transcriptomic analyses of COVID-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of SARS-CoV-2 host response genesDOI 10.1101/2020.04.13.039263
Select a neighboring publication to make it the new centre.